New Delhi: Niti Aayog member Dr VK Paul while speculating of a more serious situation in the coming days, due to the unprecedented rise in Omicron cases, said, “There is the potential scenario that our vaccines may become ineffective in emerging situations,” he said. Paul added that there is a need to create vaccines, using the same platform, to “target the variant of the day.”
“A much more concerted approach to drug development is required,” Paul said.
Also read: The final call: Last batch of farmers to vacate Ghazipur site today
Paul said that the priority right now is to make sure that there is universal vaccine coverage and that no one is left behind. He also stressed the need for investments in science to tackle the pandemic.
Paul was speaking at the CII Partnership. “Drug development will not go out of fashion for the next viral epidemic/pandemic that we might face, and the anti-microbial resistance challenge is crying for drug solutions. Lastly, it is a science of the highest quality that we need to invest in to tackle deep challenges. Our national investment in science is all public money,” he said.
Continue Reading
